download-584.jpg download-754.jpg

Our Responsibilities

Sinopep's Regulatory Affairs (RA) team works closely with all relevant functional organizations to provide global end-to-end RA services to our partners, from pre-clinical and clinical studies to product launches, including regulatory strategy consulting, technical review, dossier preparation and submission, as well as communication with regulatory agencies. The core RA team members have at least 15 years of drug registration experience, are familiar with the regulations and technical requirements of FDA, NMPA, EDQM, PMDA, etc.

Our well-trained RA staff are very familiar with different electronic submission systems in various countries and regions.

download.jpg

Services

Sinopep’s dedicated Regulatory Affairs team always carries "customer first" mindset and provides excellent value-adding services through forward-looking gap analyses and meticulous preparation of source documents.

Stages

  • R&D
  • Registration
  • Post-Marketing
  • Onsite Inspections

Services

  • download.svg

    Strategy and feasibility evaluation during CMC R&D

  • download.svg

    Regulatory compliance support during CMC manufacturing

  • download.svg

    Technical review for CMC dossiers

  • download.svg

    Preparation of bilingual dossiers (including IND, NDA, ANDA, DMF, ASMF, CEP, etc.)

  • 培训 2.png

    Dossier filing flow

  • 培训 3.png

    Facilitation of partners communication with regulatory agencies

  • 培训 1.png

    Monitoring and tracking of review progress

  • download.svg

    Change evaluation

  • 培训 2.png

    Preparation of annual reports and supplements

  • download.svg

    Onsite preparation

  • 培训 2.png

    Documents Preparation

  • 培训 3.png

    Support for onsite inspections

Experience

Over the years, Sinopep has filed over 100 dossiers to regulatory agencies such as FDA, NMPA, EDQM and PMDA covering ANDA, DMF, CEP and VMF submissions. There has been no delay or failure on deficiency response in any of our filings. Today, our APls and pharmaceutical products have been successfully marketed in over 40 countries.

  • 100+

    Dossiers filed to regulatory agencies

  • mod_logo.svg
  • 40+

    APIs or pharmaceutical products marketed

b4_img_02.jpg

Why Sinopep Regulatory Affairs?

Highly skilled and experienced RA team to meet and exceed our partners’ expectation.

  • download.svg

    Scientifically sound standard operation procedures to satisfy all technical requirements by various regulatory agencies.

  • download.svg

    Globally accepted GMP Manufacturing facilities successfully passed numerous audits by FDA, NMPA, MFDS, etc. to provide confidence and success during onsite inspection for our partners.

  • download.svg

    Multi-lingual ability to facilitate direct and effective communication with most of regulatory agencies.